The price of R1 RCM Inc. (NASDAQ:RCM) shares last traded on Wall Street fell -0.19% to $15.84.
Based on available information, 16 analysts follow R1 RCM Inc. (NASDAQ:RCM). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $26.00 and a low of $16.00, we find $19.50. Given the previous closing price of $15.87, this indicates a potential upside of 22.87 percent. RCM stock price is now 3.99% away from the 50-day moving average and 2.93% away from the 200-day moving average. The market capitalization of the company currently stands at $6.59B.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
Among analysts, 2 rate the stock a hold while 12 rate it a buy. Brokers who have rated the stock have averaged $19.44 as their price target over the next twelve months.
.
In other news, SPARBY JOHN M., President sold 20,000 shares of the company’s stock on May 10. The stock was sold for $327,280 at an average price of $16.36. Upon completion of the transaction, the President now directly owns 243,827 shares in the company, valued at $3.86 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 21, Chief Executive Officer RIVAS LEE bought 71,767 shares of the business’s stock. A total of $1,000,001 was incurred on buying the stock at an average price of $13.93. This leaves the insider owning 71,767 shares of the company worth $1.14 million. Insiders disposed of 158,813,067 shares of company stock worth roughly $2.52 billion over the past 1 year. A total of 0.80% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in RCM stock. A new stake in R1 RCM Inc. shares was purchased by NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. during the first quarter worth $1,494,880,000. JENNISON ASSOCIATES LLC invested $31,077,000 in shares of RCM during the first quarter. In the first quarter, ORBIMED ADVISORS LLC acquired a new stake in R1 RCM Inc. valued at approximately $27,720,000. MACQUARIE GROUP LTD acquired a new stake in RCM for approximately $14,764,000. SILVERCREST ASSET MANAGEMENT GROUP LLC purchased a new stake in RCM valued at around $12,778,000 in the second quarter. In total, there are 344 active investors with 85.10% ownership of the company’s stock.
A candlestick chart of R1 RCM Inc. (NASDAQ: RCM) showed a price of $15.73 on Wednesday morning. During the past 12 months, R1 RCM Inc. has had a low of $6.71 and a high of $27.07. As of last week, the company has a debt-to-equity ratio of 0.66, a current ratio of 1.60, and a quick ratio of 1.60. The fifty day moving average price for RCM is $15.28 and a two-hundred day moving average price translates $15.34 for the stock.
The latest earnings results from R1 RCM Inc. (NASDAQ: RCM) was released for Mar, 2023. According to the Health Information Services Company, earnings per share came in at $0, beating analysts’ expectations of -$0.02 by 0.02. This compares to $0.09 EPS in the same period last year. The net profit margin was 0.90% and return on equity was 0.70% for RCM. The company reported revenue of $545.6 million for the quarter, compared to $385.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 41.46 percent. For the current quarter, analysts expect RCM to generate $561.74M in revenue.
R1 RCM Inc.(RCM) Company Profile
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. R1 RCM Inc. was founded in 2003 and is headquartered in Murray, Utah.
